TPSTMa circulating tumor marker in breast cancer
โ Scribed by Roland Einarsson
- Publisher
- Association of Clinical Biochemistry of India
- Year
- 1999
- Tongue
- English
- Weight
- 543 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0970-1915
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Controversy exists in using carcinoembryonic antigen (CEA) for monitoring the clinical course of breast cancer. In this study, the kinetics of two plasma tumor markers, CEA and CA15-3, immediately after the initiation of chemotherapy were assessed in 30 patients with advanced breast cancer. Four dis
A total of 239 determinations of CEA plasma levels were performed for 83 breast cancer patients during chemotherapy or follow-up. In addition, 137 plasma samples were assayed for interferon levels. Patient clinical status was carefully scored according to objective criteria and recorded at each eval